SMi summarises the potential for single molecule imaging in Ab discovery and vaccine development SMi Systems is developing a commercial analytics platform that automates single-molecule detection and analysis. Here we describe why single-molecule measurements are likely to become the go-to approach when developing novel drugs and vaccines. VIEW PDF Lucy Eccleston11 March 2025Home News Block, 2025 Facebook0 Twitter 0 Likes
